About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Aug 3, 2021 8:54 am | eHealth
Last week, Amwell announced it was buying two digital health companies to boost its telehealth platform. The companies are SilverCloud Health, which delivers a range of digital cognitive behavioral health programs that are evidence-based and clinically validated,... Read More »
by Dylan Sammut | Aug 3, 2021 8:54 am | Medical Office Buildings, Other Services
Cornerstone Companies, Inc. announced last week it has closed on its sixth medical office building portfolio, acquiring 12 healthcare real estate properties in nine states totaling more than 155,000 square feet. The portfolio was valued at $48.7 million, or close to... Read More »
by Dylan Sammut | Aug 2, 2021 4:19 pm | Healthcare Market Updates
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our new LevinPro Healthcare and LTC platform, which is updated daily to provide our subscribers with the most... Read More »
by Dylan Sammut | Jul 27, 2021 8:43 am | Healthcare Market Updates
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our new LevinPro Healthcare and LTC platform, which is updated daily to provide our subscribers with the most... Read More »
by Dylan Sammut | Jul 27, 2021 8:26 am | Other Services
Outsourced R&D companies, such as CROs and CDMOs, have been in huge demand this year due to industry tailwinds. Biotech and pharma firms are racing to find treatment for diseases of high unmet need, and external research firms have the capabilities to help life... Read More »